09
Jun

Meet Lachman Consultants (Ireland) at Medicines for Europe in Malta June 14 – 16

Join Lachman Consultants (Ireland) in Malta for Medicines for Europe 28th Annual Conference, June 14 – 16. The three-day conference features a series of keynotes and sessions around the actions required to address public health needs and build a healthier Europe. The event will also include a discussion led by Lachman Consultants’ President and CEO, […]

Read More
22
May

Meet Lachman Consultants (Ireland) at the 2023 PDA Good Aseptic Manufacturing Conference

Join Lachman Consultants (Ireland) in Leipzig, Germany for the 2023 Parenteral Drug Association (PDA) Good Aseptic Manufacturing Conference on May 23 – 24, to discuss the implications of the new GMP Annex 1 and share insights to help you prepare. As a Gold Sponsor at this year’s event, Lachman will be represented by: John Darby, […]

Read More
11
May

Lachman Consultant Services, Inc. to Participate at This Year’s FDLI Annual Conference as a Gold Sponsor

Join Lachman Consultants at this year’s FDLI Annual Conference in Washington, DC, May 17 –18, 2023, for a two-day hybrid event that will address complex legal, regulatory, compliance, and policy issues in all facets of the FDA-regulated industry. Lachman Consultants will be represented by: Martin Shimer (Executive Director) Rachel Thompson, JD (Senior Director) David Petshaft, […]

Read More
26
Apr

Lachman Consultant Services, Inc. Announces Lachman Ireland Consultancy

Lachman Consultant Services, Inc. (Lachman Consultants), recently completed the expansion of our existing operations in Ireland to support the growing demand for services in the European region. Operating under the name Lachman Consultants (Ireland) Limited, this expanded pharmaceutical quality and regulatory consultancy is the most recent development in our global expansion to better serve the […]

Read More
08
Dec

Webinar – Excelling in a Multigenerational Workplace

On Tuesday December 13, Lachman President and CEO, Fran Zipp will be participating on a panel in a live webinar on “Excelling in a Multigenerational Workplace” as part of the DCAT Alliance for Industry Women Committee. This issue is one that transcends the pharmaceutical industry and is certainly not experienced exclusively by females. The varying […]

Read More
28
Nov

Lachman Consultants to Participate in Scrip Awards

For the past 18 years, the Scrip Awards has been taking place in London where over 400 industry leaders gather to celebrate and recognize the best innovations and achievements in the global biopharmaceutical industry. This year, Lachman CEO and President Frances Zipp and John Darby, Senior Director will be attending to celebrate the winners across […]

Read More
25
Oct

Marty Shimer to Speak at AAM’s GRx+Biosims Meeting

On Tuesday, November 8, 2022, as part of the GRx+Biosims conference being held by the Association for Accessible Medicines, Marty Shimer will be participating on a panel in the Science and Regulatory Learning Track on pH Adjusters and Q1/Q2 Assessments. This session will explore FDA’s plans for pH adjusters and Q1/Q2 assessments and provide industry […]

Read More
11
Jul

Lachman Consultant Services, Inc. Names Marty Shimer as Executive Director, Regulatory

(Westbury, NY – July 11, 2022) – Frances Zipp, President and CEO of Lachman Consultant Services, Inc. (Lachman Consultants), a leading provider of compliance, regulatory affairs, and technical services to global life sciences organizations, announced today that CAPT Martin H. Shimer, II joined the firm as Executive Director, Regulatory, effective July 11, 2022. In this […]

Read More
14
Jun

Fran Zipp to Present at Medicines for Europe

On Thursday, June 30th, at the Annual Conference of Medicines for Europe, Frances Zipp, President and CEO of Lachman Consultant Services, Inc., will be addressing the audience as a part of the Keynote Speech at the Dolce Sitges Hotel in Barcelona, Spain.  Fran will be addressing humanitarian efforts by industry to provide patients in war-torn […]

Read More
1 2 3 13